Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by threefiftynineon Jul 02, 2020 4:40pm

107 Views

Post# 31217891

---WANT TO CHAT TO A BROKER---

pp----go to ceo.ca----they will be more than welcome to have a chat with you under many aliases----makes you wonder why this offering is a shambles----hopefully very soon a PR company takes the reigns and stops this utter nonsense ---but there again--.085 and no volume just about tells the story in this day when another big player (moderna) dropped the ball and vxl dither about trying to raise funds at .085 cents----Ya-amateur theatrics

<< Previous

Bullboard Posts

Next >>

Gold, growth and sustainability in focus for Mandalay Resources